Crossref journal-article
Elsevier BV
Neuroscience (78)
Bibliography

Benn, C. L., Slow, E. J., Farrell, L. A., Graham, R., Deng, Y., Hayden, M. R., & Cha, J.-H. J. (2007). Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s disease. Neuroscience, 147(2), 354–372.

Authors 7
  1. C.L. Benn (first)
  2. E.J. Slow (additional)
  3. L.A. Farrell (additional)
  4. R. Graham (additional)
  5. Y. Deng (additional)
  6. M.R. Hayden (additional)
  7. J.-H.J. Cha (additional)
References 43 Referenced 43
  1. 10.1212/WNL.42.4.733 / Neurology / Alternative excitotoxic hypotheses by Albin (1992)
  2. 10.1002/jnr.10272 / J Neurosci Res / Striatal neurochemical changes in transgenic models of Huntington’s disease by Ariano (2002)
  3. 10.1016/0306-4522(95)00595-1 / Neuroscience / Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington’s disease: a detailed cellular in situ hybridization study by Augood (1996)
  4. 10.1038/321168a0 / Nature / Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid by Beal (1986)
  5. {'key': '10.1016/j.neuroscience.2007.03.010_bib5', 'first-page': '231', 'article-title': 'Neurotransmitter receptor analysis in transgenic mouse models', 'volume': '277', 'author': 'Benn', 'year': '2004', 'journal-title': 'Methods Mol Biol'} / Methods Mol Biol / Neurotransmitter receptor analysis in transgenic mouse models by Benn (2004)
  6. 10.1002/jnr.1244 / J Neurosci Res / NMDA receptor function in mouse models of Huntington disease by Cepeda (2001)
  7. 10.1098/rstb.1999.0449 / Philos Trans R Soc Lond B Biol Sci / Altered neurotransmitter receptor expression in transgenic mouse models of Huntington’s disease by Cha (1999)
  8. 10.1073/pnas.95.11.6480 / Proc Natl Acad Sci U S A / Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene by Cha (1998)
  9. 10.1093/hmg/11.17.1939 / Hum Mol Genet / Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington’s disease by Chan (2002)
  10. 10.1016/0166-2236(90)90111-M / Trends Neurosci / Excitotoxic injury of the neostriatum: a model for Huntington’s disease by DiFiglia (1990)
  11. 10.1046/j.1471-4159.2003.01744.x / J Neurochem / Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum by Dunah (2003)
  12. 10.1046/j.1471-4159.1996.67062335.x / J Neurochem / Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody by Dunah (1996)
  13. 10.1523/JNEUROSCI.4356-06.2007 / J Neurosci / Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington’s disease by Fan (2007)
  14. 10.1016/j.pneurobio.2006.11.003 / Prog Neurobiol / N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington’s diseas by Fan (2006)
  15. 10.1523/JNEUROSCI.11-12-03877.1991 / J Neurosci / Proliferative and degenerative changes in striatal spiny neurons in Huntington’s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry by Ferrante (1991)
  16. 10.1074/jbc.M309348200 / J Biol Chem / Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington’s disease knock-in striatal cells by Gines (2003)
  17. 10.1016/j.nbd.2005.08.007 / Neurobiol Dis / Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models by Graham (2006)
  18. 10.1016/j.neuron.2005.03.025 / Neuron / Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice by Gu (2005)
  19. 10.1016/S0896-6273(00)80764-3 / Neuron / A YAC mouse model for Huntington’s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration by Hodgson (1999)
  20. 10.1016/0092-8674(93)90585-E / Cell / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes (1993)
  21. 10.1080/00207450490430453 / Int J Neurosci / AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs by Jayakar (2004)
  22. 10.1126/science.2166337 / Science / A family of AMPA-selective glutamate receptors by Keinanen (1990)
  23. 10.1016/j.brainres.2005.01.029 / Brain Res / Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis by Kennedy (2005)
  24. 10.1523/JNEUROSCI.21-23-09112.2001 / J Neurosci / Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington’s disease by Laforet (2001)
  25. 10.1016/j.neurobiolaging.2003.04.003 / Neurobiol Aging / Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease by Li (2003)
  26. 10.1152/jn.00308.2004 / J Neurophysiol / Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease by Li (2004)
  27. 10.1016/j.nbd.2003.08.024 / Neurobiol Dis / Complex alteration of NMDA receptors in transgenic Huntington’s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation by Luthi-Carter (2003)
  28. 10.1093/hmg/9.9.1259 / Hum Mol Genet / Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease by Luthi-Carter (2000)
  29. 10.1093/hmg/11.17.1927 / Hum Mol Genet / Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington’s disease mouse models reveal context-independent effects by Luthi-Carter (2002)
  30. 10.1016/S0092-8674(00)81369-0 / Cell / Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice by Mangiarini (1996)
  31. 10.1006/exnr.1999.7327 / Exp Neurol / Decrease in striatal enkephalin mRNA in mouse models of Huntington’s disease by Menalled (2000)
  32. 10.1006/exnr.2000.7542 / Exp Neurol / The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity by Orlando (2001)
  33. 10.1212/WNL.32.12.1391 / Neurology / Quantitative autoradiography of neurotransmitter receptors in Huntington disease by Penney (1982)
  34. 10.1016/j.nbd.2005.08.001 / Neurobiol Dis / Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease by Shehadeh (2006)
  35. 10.1093/hmg/ddg169 / Hum Mol Genet / Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease by Slow (2003)
  36. 10.1074/jbc.M304240200 / J Biol Chem / Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors by Song (2003)
  37. 10.1073/pnas.0409402102 / Proc Natl Acad Sci U S A / Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington’s disease by Tang (2005)
  38. 10.1002/mds.870110209 / Mov Disord / Proton magnetic resonance spectroscopy in Huntington’s disease: evidence in favour of the glutamate excitotoxic theory by Taylor-Robinson (1996)
  39. 10.1523/JNEUROSCI.0590-05.2005 / J Neurosci / Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington’s disease by Van Raamsdonk (2005)
  40. {'key': '10.1016/j.neuroscience.2007.03.010_bib39', 'series-title': 'Huntington’s disease', 'first-page': '276', 'article-title': 'Striatal neurochemistry of Hungtington’s disease', 'author': 'Yohrling', 'year': '2002'} / Huntington’s disease / Striatal neurochemistry of Hungtington’s disease by Yohrling (2002)
  41. 10.1016/j.mcn.2003.11.014 / Mol Cell Neurosci / Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington’s disease by Zeron (2004)
  42. 10.1016/S0896-6273(02)00615-3 / Neuron / Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington’s disease by Zeron (2002)
  43. 10.1093/hmg/ddi014 / Hum Mol Genet / Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington’s disease: neuronal selectivity and potential neuroprotective role of HAP1 by Zucker (2005)
Dates
Type When
Created 18 years, 2 months ago (June 5, 2007, 7:11 a.m.)
Deposited 3 years, 8 months ago (Dec. 5, 2021, 12:53 p.m.)
Indexed 5 months ago (March 31, 2025, 12:49 a.m.)
Issued 18 years, 3 months ago (June 1, 2007)
Published 18 years, 3 months ago (June 1, 2007)
Published Print 18 years, 3 months ago (June 1, 2007)
Funders 0

None

@article{Benn_2007, title={Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s disease}, volume={147}, ISSN={0306-4522}, url={http://dx.doi.org/10.1016/j.neuroscience.2007.03.010}, DOI={10.1016/j.neuroscience.2007.03.010}, number={2}, journal={Neuroscience}, publisher={Elsevier BV}, author={Benn, C.L. and Slow, E.J. and Farrell, L.A. and Graham, R. and Deng, Y. and Hayden, M.R. and Cha, J.-H.J.}, year={2007}, month=jun, pages={354–372} }